Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2020-09-28 Sale |
2020-09-30 9:30 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
42,779 | $109.04 | $4,664,546 | 74,525 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:29 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
44,949 | $108.84 | $4,892,300 | 76,561 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:28 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
43,568 | $109.04 | $4,750,547 | 96,137 (Direct) |
View |
2020-09-28 Sale |
2020-09-30 9:27 pm |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
30,450 | $110 | $3,349,481 | 182,727 (Direct) |
View |
2020-08-18 Sale |
2020-08-20 6:25 pm |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
42,788 | $148.78 | $6,366,182 | 31,045 (Direct) |
View |
2020-08-18 Sale |
2020-08-20 6:22 pm |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
8,000 | $146 | $1,168,000 | 9,951 (Direct) |
View |
2020-08-18 Sale |
2020-08-20 6:20 pm |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
46,242 | $144.33 | $6,673,982 | 23,315 (Direct) |
View |
2020-08-18 Sale |
2020-08-20 6:14 pm |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
55,921 | $145.2 | $8,119,860 | 33,743 (Direct) |
View |
2020-08-18 Sale |
2020-08-20 6:09 pm |
NOVAVAX INC | NVAX | EVANS GARY C Director |
10,500 | $150.44 | $1,579,620 | 329,979 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2020-09-28 Exercise |
2020-09-30 9:30 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
24,750 | $5.95 | 74,525 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:30 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
24,750 | $0 | 74,525 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:29 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
25,000 | $5.95 | 76,561 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:29 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
25,000 | $0 | 76,561 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:28 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
29,600 | $5.95 | 96,137 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:28 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
29,600 | $0 | 96,137 (Direct) |
View |
2020-09-28 Tax Withholding |
2020-09-30 9:28 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
2,103 | $111.18 | 96,137 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:27 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
25,000 | $5.95 | 182,727 (Direct) |
View |
2020-09-28 Exercise |
2020-09-30 9:27 pm |
N/A 2029-09-26 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
50,000 | $0 | 182,727 (Direct) |
View |
2020-09-28 Tax Withholding |
2020-09-30 9:27 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
11,429 | $111.18 | 182,727 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
2,434 | $113.56 | 37,698 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:16 pm |
N/A N/A |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
6,546 | $0 | 37,698 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
17,117 | $113.56 | 30,484 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:15 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
35,438 | $0 | 30,484 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:12 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
18,639 | $113.56 | 21,510 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:12 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
38,588 | $0 | 21,510 (Direct) |
View |
2020-09-26 Tax Withholding |
2020-09-29 6:11 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
16,844 | $113.56 | 26,250 (Direct) |
View |
2020-09-26 Exercise |
2020-09-29 6:11 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
34,873 | $0 | 26,250 (Direct) |
View |
2020-08-24 Option Award |
2020-08-26 5:29 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
125,000 | $0 | 125,000 (Direct) |
View |
2020-08-24 Option Award |
2020-08-26 5:27 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
140,000 | $0 | 140,000 (Direct) |
View |
2020-08-24 Option Award |
2020-08-26 5:26 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
165,000 | $0 | 165,000 (Direct) |
View |
2020-08-24 Option Award |
2020-08-26 5:24 pm |
N/A 2030-04-17 |
NOVAVAX INC | NVAX | Erck Stanley C President and CEO |
400,000 | $0 | 400,000 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
7,807 | $27 | 31,045 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
11,249 | $99.8 | 31,045 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
13,322 | $27.6 | 31,045 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:25 pm |
N/A 2026-03-15 |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
42,788 | $0 | 31,045 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:25 pm |
N/A N/A |
NOVAVAX INC | NVAX | Trizzino John EVP, CBO and CFO |
10,410 | $46 | 31,045 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:22 pm |
N/A N/A |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
4,000 | $27.6 | 9,951 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:22 pm |
2018-03-16 2027-03-16 |
NOVAVAX INC | NVAX | MCMANUS MICHAEL A JR Director |
8,000 | $0 | 9,951 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,345 | $27 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
7,499 | $36.6 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
11,249 | $99.8 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
2,499 | $91 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
13,322 | $27.6 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A 2021-03-10 |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
46,242 | $0 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
8,328 | $46 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:20 pm |
N/A N/A |
NOVAVAX INC | NVAX | Herrmann John A III EVP, Chief Legal Officer |
1,000 | $50 | 23,315 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
10,933 | $27 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
4,405 | $36.6 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
7,500 | $25.6 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
16,658 | $27.6 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A 2021-03-10 |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
55,921 | $0 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
13,225 | $46 | 33,743 (Direct) |
View |
2020-08-18 Gift |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
1,528 | $0 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:14 pm |
N/A N/A |
NOVAVAX INC | NVAX | Glenn Gregory M President, R&D |
3,200 | $50 | 33,743 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
1,500 | $36.6 | 329,979 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
4,000 | $27.6 | 329,979 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:09 pm |
2011-09-10 2021-03-10 |
NOVAVAX INC | NVAX | EVANS GARY C Director |
10,500 | $0 | 329,979 (Direct) |
View |
2020-08-18 Exercise |
2020-08-20 6:09 pm |
N/A N/A |
NOVAVAX INC | NVAX | EVANS GARY C Director |
1,000 | $50 | 329,979 (Direct) |
View |